Tag Archives: Callon Petroleum Co

Callon Petroleum has more upside ahead

ArcBest: “I like trucking. I like ArcBest, but you know what, we did that really good compare last night of Union Pacific versus CSX, and Union Pacific’s intermodal business is really good. I’d rather go with diversification.”

Roblox: “We’re getting young people in. Now here’s the problem with Roblox: It’s good for you … not good for a lot of others. That’s because ever since the Fed changed its tune back in November, the market is too angry to like these long-term [growth stocks], but it’s OK for you. You’ve got your whole life ahead of you. You should be a buyer of Roblox because it’s a great company.”

Ulta Beauty: “I think Ulta is shooting the lights out. I think Dave Kimbell is doing a fantastic job. I think Ulta is one of the retailers that I want to own down in steps — $315, then maybe $300 pick some up. They’re really doing well.”

Jazz Pharmaceuticals: “I liked Jazz at one time, but Jazz is … a very inexpensive company. I have to reopen why it’s so inexpensive because holy cow, something is not right there, so let me come back.”

Callon Petroleum: “No, you haven’t made anything yet. Callon is real. I think you’ve got more room, more room on the upside. You stay long that.”

Zynga: “That one is over. I mean, Take-Two [Interactive] is buying it. There’s consolidation going on in this industry. It’s incredible. And by the way, last night on the Microsoft call, you could see why they’re buying Activision Blizzard. It’s going to make so much sense. Buy Microsoft.”

The New York Times Company: “I happen to like that CEO [Meredith Kopit Levien]. She’s sensational. I wish she talked to me. As much as I like the Athletic, she overpaid. … The New York Times is a great company, but they paid a little too much for that and that has really hurt the valuation. I am sorry because I think it’s a fantastic product, both of them.”

F5: “This is the guys who control basically the ‘red light, green light internet highway,’ but they did have a supply problem, and there’s no room for mistakes anymore in any technology company.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com



Read original article here

Pfizer, Occidental Petroleum, Bank of America and more

A syringe is filled with a dose of Pfizer’s coronavirus disease (COVID-19) vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021.

Brendan McDermid | Reuters

Check out the companies making headlines before the bell:

China Evergrande Group — Chinese property giant Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets. The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.

Pfizer — The pharmaceutical giant said Monday that trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.

Laredo Petroleum, Occidental Petroleum — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&P Oil & Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.

Colgate-Palmolive — The consumer staples stock was upgraded to buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.

JPMorgan, Bank of America — Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.

AstraZeneca — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.

ARK Innovation ETF — Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.

— with reporting from CNBC’s Jesse Pound and Yun Li.

Read original article here